These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6203492)

  • 1. The syndrome of partial mole.
    Wong LC; Ma HK
    Arch Gynecol; 1984; 234(3):161-6. PubMed ID: 6203492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful resolution of persistent trophoblastic disease after partial mole with the EMA-CO regimen.
    Dgani R; Zalel Y; Biran H; Blickstein I; Caspi B; Weissman A; Shoham Z
    Eur J Obstet Gynecol Reprod Biol; 1994 Mar; 54(1):77-9. PubMed ID: 7519153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial hydatidiform moles: a review.
    Watson EJ; Hernandez E; Miyazawa K
    Obstet Gynecol Surv; 1987 Sep; 42(9):540-4. PubMed ID: 2443883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hydatidiform mole, trophoblastic tumor/choriocarcinoma].
    Luschin-Ebengreuth G; Petru E; Pickel H
    Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():125-6. PubMed ID: 1337488
    [No Abstract]   [Full Text] [Related]  

  • 6. Partial hydatidiform mole with false-negative urine human chorionic gonadatropin test in the emergency department.
    Mundangepfupfu T; Waseem M
    J Emerg Med; 2014 Mar; 46(3):348-50. PubMed ID: 24188605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
    van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
    Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinicopathologic profile of the partial hydatidiform mole.
    Szulman AE; Surti U
    Obstet Gynecol; 1982 May; 59(5):597-602. PubMed ID: 7070731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of partial molar pregnancy.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Obstet Gynecol; 1985 Nov; 66(5):677-81. PubMed ID: 2414703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of 309 cases after hydatidiform mole: different follow-up program according to biologic behavior.
    Bolis G; Belloni C; Bonazzi C; Mangili G; Presti M; Zanaboni F; Mangioni C
    Tumori; 1988 Feb; 74(1):93-6. PubMed ID: 2451334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy.
    Lage JM; Mark SD; Roberts DJ; Goldstein DP; Bernstein MR; Berkowitz RS
    Obstet Gynecol; 1992 Mar; 79(3):403-10. PubMed ID: 1371185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
    Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
    Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles.
    Berkowitz R; Ozturk M; Goldstein D; Bernstein M; Hill L; Wands JR
    Obstet Gynecol; 1989 Aug; 74(2):212-6. PubMed ID: 2473429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation?
    Braga A; Torres B; Burlá M; Maestá I; Sun SY; Lin L; Madi JM; Uberti E; Viggiano M; Elias KM; Berkowitz RS
    Gynecol Oncol; 2016 Dec; 143(3):558-564. PubMed ID: 27640962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational trophoblastic disease: what have we learned in the past decade?
    Jones WB
    Am J Obstet Gynecol; 1990 May; 162(5):1286-95. PubMed ID: 2160194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gestational trophoblastic disease. A comparative study of the results of therapy in patients with invasive mole and with choriocarcinoma.
    Brewer JI; Eckman TR; Dolkart RE; Torok EE; Webster A
    Am J Obstet Gynecol; 1971 Jan; 109(2):335-40. PubMed ID: 5539127
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevated sera levels of SP-1 induced by chemotherapy in patients with metastatic gestational trophoblastic diseases.
    Göcze PM; Than GN; Szabò DG; Csaba IF; Bohn H
    Oncology; 1990; 47(5):406-9. PubMed ID: 1699189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary oral etoposide therapy in gestational trophoblastic disease. An update.
    Wong LC; Choo YC; Ma HK
    Cancer; 1986 Jul; 58(1):14-7. PubMed ID: 3011237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subsequent pregnancy outcome in patients with spontaneous resolution of HCG after evacuation of hydatidiform mole: comparison between complete and partial mole.
    Matsui H; Iitsuka Y; Suzuka K; Seki K; Sekiya S
    Hum Reprod; 2001 Jun; 16(6):1274-7. PubMed ID: 11387305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.